UNSPSC 51434102: Chlorisondamine

This classification denotes a nicotinic antagonist with the molecular formula C14H20Cl4N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JD3M24F66I, chemically known as 1h-isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2- (trimethylammonio)ethyl)- but generally known as chlorisondamine, which bears US NIH Compound Identifier 6243. European Medicines Agency schedules Chlorisondamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06182MIG.

The term CHLORISONDAMINE is an International Non-Proprietary Name. As of Q4 2014, CHLORISONDAMINE remains the US FDA Preferred Term for this commodity. Chlorisondamine bears US NLM identifiers UMLS ID C0008211 and NCI Concept Code C83619. SMILES: C[N+]1(CC2=C(C1)C(=C(C(=C2Cl)Cl)Cl)Cl)CC[N+](C)(C)C.[Cl-].

UNSPSC 51434102 Chlorisondamine is a Commodity-tier code encompassing advanced life support medications and related pharmaceutical products procured by emergency medical services and fire departments. State and local governments use this code to acquire injectable medications critical to pre-hospital emergency care, including vasopressors, cardiac agents, and related compounds. Recent solicitations show that municipalities procure these medications in specific unit quantities tied to operational needs, with strict requirements for expiration dating, shelf-life guarantees, rapid delivery, and full warranty coverage against defects. Issuing bodies include municipal fire and EMS departments operating within counties and cities; the Tampa Fire Rescue department in Hillsborough County, Florida represents a current active buyer under this code.

The City of Tampa Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026 for Advanced Life Support Medications with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00. The solicitation specified four medication line items—Labetalol HCI 100mg vials, Epinephrine 1:10,000 injections, Adenosine 6mg vials, and Diltiazem 25mg vials—with delivery within ten calendar days of order and nine-month minimum expiration dating from acceptance. The contract term runs one year from award with two optional one-year renewals plus unilateral extension rights for three additional 30-day periods at the same terms. The City designated the procurement with a Small Local Business Enterprise (SLBE) sheltered market designation offering a 5 percent bid discount for SLBE participation not to exceed $10,000, and required all vendors to submit OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. Electronic bids were due through the OpenGov eProcurement Portal by 3:00 pm on April 8, 2026, with award to the lowest responsive, responsible bidder within 120 days of bid opening.